Faruqi & Faruqi represents a proposed class of pediatricians and pediatric practice groups challenging Sanofi-Pasteur, Inc.’s illegal maintenance of a monopoly on the children’s vaccine Menactra in violation of § 2 of the Sherman Act. Plaintiffs allege a scheme where Sanofi-Pasteur employs a series of anticompetitive and exclusionary bundling and tying contracts with multiple physician buying groups across the United States to preserve their monopoly on Menactra. As a result of Sanofi-Pasteur’s conduct, plaintiffs paid more for Menactra than they would have in a competitive market.
Send Information
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.
Details
Filed on 12/09/2011
Office
1617 JFK Boulevard, Suite 1550
19103 Philadelphia, Pennsylvania
Phone (215) 277-5770
Fax (215) 277-5771
Counsel
Peter Kohn pkohn@faruqilaw.com Phone (215) 277-5770 Fax (215) 277-5771
Joseph T. Lukens jlukens@faruqilaw.com Phone (215) 277-5770 Fax (215) 277-5771